相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
Simon D. Harding et al.
NUCLEIC ACIDS RESEARCH (2018)
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
Michael J. Curtis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
2-Deoxy-D-Glucose Ameliorates PKD Progression
Marco Chiaravalli et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis
Danielle K. DePeralta et al.
CANCER (2016)
Recent advances in autosomal-dominant polycystic kidney disease
G. K. Rangan et al.
INTERNAL MEDICINE JOURNAL (2016)
Metformin use and survival from lung cancer: A population-based cohort study
Una C. Mc Menamin et al.
LUNG CANCER (2016)
Inhibition of Aerobic Glycolysis Attenuates Disease Progression in Polycystic Kidney Disease
Meliana Riwanto et al.
PLOS ONE (2016)
PKD1 Mono-Allelic Knockout Is Sufficient to Trigger Renal Cystogenesis in a Mini-Pig Model
Jin He et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2015)
Warburg Effect or Reverse Warburg Effect? A Review of Cancer Metabolism
Xiao Dong Xu et al.
ONCOLOGY RESEARCH AND TREATMENT (2015)
Alleviating exercise-induced muscular stress using neat and processed bee pollen: oxidative markers, mitochondrial enzymes, and myostatin expression in rats
Sameer Ketkar et al.
INTEGRATIVE MEDICINE RESEARCH (2015)
Role of AMP-Activated Protein Kinase in Cancer Therapy
Gauhar Rehman et al.
ARCHIV DER PHARMAZIE (2014)
Defective metabolism in polycystic kidney disease: potential for therapy and open questions
Isaline Rowe et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy
Isaline Rowe et al.
NATURE MEDICINE (2013)
Analyses of pig genomes provide insight into porcine demography and evolution
Martien A. M. Groenen et al.
NATURE (2012)
Swine as Models in Biomedical Research and Toxicology Testing
M. M. Swindle et al.
VETERINARY PATHOLOGY (2012)
Contribution of Large Pig for Renal Ischemia-Reperfusion and Transplantation Studies: The Preclinical Model
S. Giraud et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Dual Inhibition of Tumor Energy Pathway by 2-Deoxyglucose and Metformin Is Effective against a Broad Spectrum of Preclinical Cancer Models
Jae-Ho Cheong et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis
Vinita Takiar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells
Issam Ben Sahra et al.
CANCER RESEARCH (2010)
Targeting Tumor Metabolism With 2-Deoxyglucose in Patients With Castrate-Resistant Prostate Cancer and Advanced Malignancies
Mark Stein et al.
PROSTATE (2010)
Polycystic Kidney Disease
Peter C. Harris et al.
ANNUAL REVIEW OF MEDICINE (2009)
Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: Present status and future prospects
B. S. Dwarakanath et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2009)
Polycystin-1 Regulates Extracellular Signal-Regulated Kinase-Dependent Phosphorylation of Tuberin To Control Cell Size through mTOR and Its Downstream Effectors S6K and 4EBP1
Gianfranco Distefano et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Molecular mechanisms of mTOR-mediated translational control
Xiaoju Max Ma et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
In vitro metformin anti-neoplastic activity in epithelial ovarian cancer
Walter H. Gotlieb et al.
GYNECOLOGIC ONCOLOGY (2008)
Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys
Masaya Baba et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
AMPK and raptor: Matching cell growth to energy supply
D. Grahame Hardie
MOLECULAR CELL (2008)
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
I. Ben Sahra et al.
ONCOGENE (2008)
Autosomal dominant polycystic kidney disease
Vicente E. Torres et al.
LANCET (2007)
The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease
JM Shillingford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions
JC Maher et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype
T Yamaguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys
T Yamaguchi et al.
KIDNEY INTERNATIONAL (2003)
Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease
S Nagao et al.
KIDNEY INTERNATIONAL (2003)
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I
MY El-Mir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
